Department of Pediatrics, Dortcelik Children's Hospital, Bursa, Turkey.
Department of Neonatology, Dortcelik Children's Hospital, Bursa, Turkey.
Fetal Pediatr Pathol. 2023 Aug;42(4):589-598. doi: 10.1080/15513815.2023.2178866. Epub 2023 Feb 22.
We investigated the relationship between 25-hydroxyvitamin D (25-OHD) levels and the development of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants.
Newborns having a gestational age (GA) of ≤32 weeks with hsPDA consisted the study group ( = 25, 20%), while newborns ≤32 weeks of GA without PDA/hsPDA were the control group ( = 97, 80%).
The study group had lower GA, birth weight (BW) and 25-OHD levels ( < 0.0001, = 0.002 and = 0.003, respectively). After adjusting for the effects of GA, BW and the presence of respiratory distress syndrome, multivariable logistic regression analyses demonstrated that preterm infants with low 25-OHD levels were 6.407 (95% CI: 1.656-24.788, = 0.007) times more likely to experience hsPDA than preterm infants with normal 25-OHD levels. Every 1 ng/mL increase in 25-OHD levels decreased the probability of hsPDA (OR: 0.894, 95% CI: 0.816-0.98, = 0.016). Low 25-OHD levels may have a role in the development of hsPDA.
我们研究了 25-羟维生素 D(25-OHD)水平与早产儿发生血流动力学意义未闭动脉导管(hsPDA)的关系。
本研究纳入胎龄(GA)≤32 周伴 hsPDA 的新生儿为研究组( = 25,20%),同期纳入胎龄(GA)≤32 周无 PDA/hsPDA 的新生儿为对照组( = 97,80%)。
研究组的 GA、出生体重(BW)和 25-OHD 水平更低( < 0.0001, = 0.002 和 = 0.003)。多变量逻辑回归分析显示,在校正 GA、BW 和呼吸窘迫综合征的影响后,25-OHD 水平低的早产儿发生 hsPDA 的可能性是 25-OHD 水平正常早产儿的 6.407 倍(95%CI:1.656-24.788, = 0.007)。25-OHD 水平每增加 1ng/mL,hsPDA 的可能性就降低(OR:0.894,95%CI:0.816-0.98, = 0.016)。低 25-OHD 水平可能与 hsPDA 的发生有关。